Copper-induced hepatitis: The COMMD1 deficient dog as a translational animal model for human chronic hepatitis

Veterinary Quarterly

Volumn 31, Issue 1, 2011, Pages 49-60

  Favier, R P ^a   Spee, B ^a   Penning, L C ^a   Rothuizen, J ^a  

^a UTRECHT UNIVERSITY   (Netherlands)

Author keywords

Animal model; Copper; Dog; Fibrosis; Hepatitis; Regeneration; Wilson's disease

Indexed keywords

CATALASE; COPPER; COPPER ZINC SUPEROXIDE DISMUTASE; CYTOKINE; GLUTATHIONE PEROXIDASE; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; REACTIVE OXYGEN METABOLITE; SCATTER FACTOR; STAT3 PROTEIN; TISSUE INHIBITOR OF METALLOPROTEINASE; TRANSFORMING GROWTH FACTOR BETA1;

APOPTOSIS; CELL DIFFERENTIATION; CELL PROLIFERATION; CHRONIC HEPATITIS; COMMD1 GENE; COPPER INDUCED HEPATITIS; GENE; HISTOPATHOLOGY; HUMAN; LIVER CELL; LIVER DISEASE; LIVER FIBROSIS; LIVER INJURY; LIVER NECROSIS; LIVER REGENERATION; MOLECULAR MECHANICS; NONHUMAN; ORGAN TRANSPLANTATION; OXIDATIVE STRESS; REVIEW; STELLATE CELL; STEM CELL; WILSON DISEASE;

ADAPTOR PROTEINS, SIGNAL TRANSDUCING; ANIMALS; COPPER; DISEASE MODELS, ANIMAL; DOG DISEASES; DOGS; DRUG-INDUCED LIVER INJURY; HEPATITIS, CHRONIC; HEPATOLENTICULAR DEGENERATION; HUMANS; LIVER CIRRHOSIS; LIVER REGENERATION; MICE; OXIDATIVE STRESS; RATS;

ANIMALIA; CANIS FAMILIARIS; MAMMALIA; OVIS ARIES; SUIDAE;

EID: 80054724654     PISSN: 01652176     EISSN: 18755941     Source Type: Journal    
DOI: 10.1080/01652176.2011.563146     Document Type: Review

References (106)

1. Apte U, Thompson MD, Cui S, Liu B, Cieply B, Monga SP. 2008. Wnt/_-catenin signaling mediates oval cell response in rodents. Hepatology. 47(1):288-295.
2. Bearn AG, Kunkel HG. 1953. Genetic and biochemical aspects of Wilson's disease. Am J Med. 15(4):442-446.
3. Biasio W, Chang T, McIntosh CJ, McDonald FJ. 2004. Identification of Murr1 as a regulator of the human delta epithelial sodium channel. J Biol Chem. 279(7):5429-5434.
4. Biempica L, Rauch H, Quintana N, Sternlieb I. 1988. Morphologic and chemical studies on a murine mutation (toxic milk mice) resulting in hepatic copper toxicosis. Lab Invest. 59(4):500-508.
5. Bird TG, Lorenzini S, Forbes SJ. 2008. Activation of stem cells in hepatic diseases. Cell Tissue Res. 331(1):283-300.
6. Bonis PA, Friedman SL, Kaplan MM. 2001. Is liver fibrosis reversible? N Eng J Med. 344(6):452-454.
7. Borowiak M, Garratt AN, Wüstefeld T, Strehle M, Trautwein C, Birchmeier C. 2004. Met provides essential signals for liver regeneration. Proc Natl Acad Sci USA. 101(29):10608-10613.
8. Bremner I. 1998. Manifestations of copper excess. Am J Clin Nutr. 67(5 Suppl):1069S-1073S.
9. Brewer GJ, Terry CA, Aisen AM, Hill GM. 1987. Worsening of neurologic syndrome in patients with Wilson's disease with metal penicillamine therapy. Arch Neurol. 44(5):490-493.
10. Buiakova OI, Xu J, Lutsenko S, Zeitlin S, Das K, Das S, Ross BM, Mekios C, Scheinberg IH, Gilliam TC. 1999. Null mutation of the murine ATP7B (Wilson disease) gene results in intracellular copper accumulation and late-onset hepatic nodular transformation. Hum Mol Genet. 8(9):1665-1671.
11. Burke ZD, Tosh D. 2006. The Wnt/beta-catenin pathway: master regulator of liver zonation? Bioessays. 28(11):1072-1077.
12. Burkhead JL, Organ CT, Shinde U, Haddock G, Lutsenko S. 2009. COMMD1 forms oligomeric complexes targeted to the endocytic membranes via specific interactions with phosphatidylinositol 4,5-biphosphate. J Biol Chem. 284(1):696-707.
13. Burstein E, Ganesh L, Dick RD, van De Sluis B, Wilkinson JC, Klomp LW, Wijmenga C, Brewer GJ, Nabel GJ, Duckett CS. 2004. A novel role for XIAP in copper homeostasis through regulation of MURR1. EMBO J. 23(1):244-254.
14. Canbay A, Friedman S, Gores GJ. 2004. Apoptosis: the nexus of liver injury and fibrosis. Hepatology. 39(2):273-278.
15. Cassiman D, Libbrecht L, Desmet V, Denef C, Roskams T. 2002. Hepatic stellate cell/myofibroblast subpopulations in fibrotic human and rat livers. J Hepatol. 36(2): 200-209.
16. Cisternas FA, Tapia G, Arredondo M, Cartier-Ugarte D, Romanque P, Sierralta WD, Vial MT, Videla LA, Araya M. 2005. Early histological and functional effects of chronic copper exposure in rat liver. Biometals. 18(5):541-551.
17. Coronado V, Nanji M, Cox DW. 2001. The Jackson toxic milk mouse as a model for copper loading. Mamm Genome. 12(10):793-795.
18. Costa NJ, Dahm CC, Hurrell F, Taylor ER, Murphy MP. 2003. Interactions of mitochondrial thiols with nitric oxide. Antioxid Redox Signal. 5(3):291-305.
19. Coyle P, Philcox JC, Carey LC, Rofe AM. 2002. Metallothionein: the multipurpose protein. Cellular and Molecular Life Sciences. 59:627-47.
20. Culotta VC, Gitlin JD. 2001. Disorders of copper transport. In: Scriver CR, Beauclet AL, Sly W, Valle D, editors. Vol. II. The metabolic and molecular bases of inherited disease. New York (NY): McGraw-Hill. p. 3105-3126.
21. Darnell Jr JE. 1997. STATs and gene regulation. Science. 277(5332):1630-1635.
22. de Bie P, Muller P, Wijmenga C, Klomp LW. 2007a. Molecular pathogenesis of Wilson and Menkes disease; correlation of mutations with molecular defects and disease phenotypes. J Med Gen. 44(11):673-88.
23. de Bie P, van de Sluis B, Burstein E, van de Berghe PV, Muller P, Berger R, Gitlin JD, Wijmenga C, Klomp LW. 2007b. Distinct Wilson's disease mutations in ATP7B are associated with enhanced binding to COMMD1 and reduced stability of ATP7B. Gastroenterology. 133(4):1316-1326.
24. Fausto N, Campbell JS. 2003. The role of hepatocytes and oval cells in liver regeneration and repopulation. Mech Dev. 120(1):117-130.
25. Fausto N, Campbell JS, Riehle KJ. 2006. Liver regeneration. Hepatology. 43(2 suppl 1):S45-S53.
26. Ferenci P, Gilliam TC, Gitlin JD, Packman S, Schilsky ML, Sokol RJ, Sternlieb I. 1996. An international symposium on Wilson's and Menkes'diseases. Hepatology. 24(4):952-958.
27. Fisher RA, Strom SC. 2006. Human hepatocyte transplantation: worldwide results. Transplantation. 82(4):441-449.
28. Friedman SL. 2003. Liver fibrosis-from bench to bedside. J Hepatol. 38(Suppl 1):S38-S53.
29. Fuentealba I, Haywood S, Trafford J. 1989. Variations in the intralobular distribution of copper in the livers of copperloaded rats in relation to the pathogenesis of copper storage disease. J Comp Path. 100(1):1-11.
30. Fuentealba IC, Aburto EM. 2003. Animal models of copperassociated liver disease. Comp Hepatol. 3;2(1):5.
31. Gaetke LM, Chow CK. 2003. Copper toxicity, oxidative stress, and antioxidant nutrients. Toxicology. 189(1-2):147-163.
32. Ganesh L, Burstein E, Guha-Niyogi A, Louder MK, Mascola JR, Klomp LW, Wijmenga C, Duckett CS, Nabel GJ. 2003. The gene product Murr1 restricts HIV-1 replication in resting CD4{thorn} lymphocytes. Nature. 426(6968):853-857.
33. Green DR, Reed JC. 1998. Mitochondria and apoptosis. Science. 281(5381):1309-1312.
34. Hengartner MO. 2000. The biochemistry of apoptosis. Nature. 407(6805):770-776.
35. Hoffmann G, van den Ingh TSGAM, Bode P, Rothuizen J. 2006. Copper-associated chronic hepatitis in Labrador Retrievers. J Vet Intern Med. 20(4):856-861.
36. Hu M, Kurobe M, Jeong YJ, Fuerer C, Ghole S, Nusse R, Sylvester KG. 2007. Wnt/_-catenin signaling in murine hepatic transit amplifying progenitor cells. Gastroenterology. 133(5):1579-1591.
37. Huh CG, Factor VM, Sánchez A, Uchida K, Conner EA, Thorgeirsson SS. 2004. Hepatocyte growth factor/c-met signalling pathway is required for efficient liver regeneration and repair. Proc Natl Acad Sci USA. 101(13):4477-4482.
38. Huster D, Finegold MJ, Morgan CT, Burkhead JL, Nixon R, Vanderwerf SM, Gilliam CT, Lutsenko S. 2006. Consequences of copper accumulation in the livers of the Atp7b-/-(Wilson disease gene) knockout mice. Am J Pathol. 168(2):423-434.
39. Huster D, Purnat TD, Burkhead JL, Ralle M, Fiehn O, Stuckert F, Olson NE, Teupser D, Lutsenko S. 2007. High copper selectively alters lipid metabolism and cell cycle machinery in the mouse model of Wilson disease. J Biol Chem. 282(11):8343-8355.
40. IJzer J, Schotanus BA, Vander Borght S, Roskams TA, Kisjes R, Penning LC, Rothuizen J, van den Ingh TSGAM. 2010. Characterisation of the hepatic progenitor cell compartment in normal liver and in hepatitis: an immunohistochemical comparison between dog and man. Vet J. 184(3):308-314.
41. Iredale JP. 2007. Models of liver fibrosis: exploring the dynamic nature of inflammation and repair in a solid organ. J Clin Invest. 117(3):539-548.
42. Jakubowski A, Ambrose C, Parr M, Lincecum JM, Wang MZ, Zheng TS, Browning B, Michaelson JS, Baetscher M, Wang B, et al. 2005. TWEAK induces liver progenitor cell proliferation. J Clin Invest. 115(9):2330-2340.
43. Jones DL, Wagers AJ. 2008. No place like home: anatomy and function of the stem cell niche. Nat Rev Mol Cell Biol. 9(1):11-12.
44. Kim R, Emi M, Tanabe K, Murakami S, Uchida Y, Arihiro K. 2006. Regulation and interplay of apoptotic and non-apopototic cell death. J Pathol. 208(3):319-326.
45. Koopman WJ, Nijtmans LG, Dieteren CE, Roestenberg P, Valsecchi F, Smeitink JA, Willems PH. 2010. Mammalian mitochondrial complex I: biogenesis, regulation and reactive oxygen species generation. Antioxid Redox Signal. 12(12):1431-1470.
46. Kordes C, Sawitza I, Häussinger D. 2008. Canonical Wnt signaling maintains the quiescent stage of hepatic stellate cells. Biochem Biophys Res Commun. 367(1):116-123.
47. Kroemer G, Galluzzi L, Vandenabeele P, Abrams J, Alnemri ES, Baehrecke EH, Blagosklonny MV, El-Deiry WS, Golstein P, Green DR, et al. 2009. Classification of cell death: recommendations of the Nomenclature Committee on Cell Death (2009). Cell Death Differ. (2009). 16(8):3-11.
48. Kung JW, Forbes SJ. 2009. Stem cells and liver repair. Curr Opin Biotechnol. 20(5):1-7.
49. LeCouter J, Moritz DR, Li B, Phillips GL, Liang XH, Gerber HP, Hillan KJ, Ferrara N. 2003. Angiogenesisindependent endothelial protection of liver: role of VEGFR-1. Science. 22(5608):309-325.
50. Libbrecht L, Roskams T. 2002. Hepatic progenitor cells in human liver diseases. Semin Cell Dev Biol. 13(6):389-396.
51. Los M, Van de Craen M, Penning LC, Schenk H, Westendorp M, Baeuerle PA, Dröge W, Krammer PH, Fiers W, Schulze-Osthoff K. 1995. Requirement of an ICE/CED-3 protease for Fas/APO-1 mediated apoptosis. Nature. 375(6526):81-83.
52. Lutsenko S. 2008. Atp7b-/-mice as a model for studies of Wilson's disease. Biochem Soc Trans. 36(Pt6):1233-1238.
53. Lutsenko S. 2010. Human copper homeostasis: a network of interconnected pathways. Curr Opinion Chem Biol. 14(2):211-217.
54. Lutsenko S, Petris MJ. 2003. Function and regulation of the mammalian copper-transporting atpases: insights from biochemical and cell biological approaches. J Membr Biol. 191(1):1-12.
55. Maine GN, Burstein E. 2007. COMMD proteins: COMMing to the scene. Cell Mol Life Sci. 64(15):1997-2005.
56. Maine GN, Mao X, Muller PA, Komarck CM, Klomp LW, Burstein E. 2009. COMMD1 expression is controlled by critical residues that determine XIAP binding. Biochem J. 417(2):601-609.
57. Masuda R, Yoshida MC, Sasaki M, Dempo K, Mori M. 1988. High susceptibility to hepatocellular carcinoma development in LEC rats with hereditary hepatitis. Jpn J Cancer Res. 79(7):828-835.
58. McCord JM, Fridovich I. 1969. Superoxide dismutase. An enzymic function for erythrocuprein (hemocuprein). J Biol Chem. 244(22):6049-6055.
59. Mercer JF. 2001. The molecular basis of copper-transport diseases. Trends Mol Med. 7(2): 64-69.
60. Miao L, St Clair DK. 2009. Regulation of superoxide dismutase genes: implications in disease. Free Radic Biol Med. 47(4):344-356.
61. Michalopoulos GK. 2007. Liver regeneration. J Cell Physiol. 213(2):286-300.
62. Michalopoulos GK, DeFrances MC. 1997. Liver regeneration. Science. 276(5309):60-66.
63. Mohammed FF, Pennington CJ, Kassiri Z, Rubin Js, Soloway PD, Ruther U, Edwards DR, Khokha R. 2005. Metalloproteinase inhibitor TIMP-1 affects hepatocyte cell cycle via HGF activation in murine liver regeneration. Hepatology. 41(4):857-867.
64. Murphy G, Atkinson S, Ward R, Gavrilovic J, Reynolds JJ. 1992. The role of plasminogen activators in the regulation of connective tissue metalloproteinases. Ann N Y Acad Sci. 4(667):1-12.
65. Naldini L, Tamagnone L, Vigna E, Sachs M, Hartmann G, Birchmeier W, Daikura Y, Tsubouchi H, Blasi F, Comoglio PM. 1992. Extracellular proteolytic cleavage by urokinase is required for activation of hepatocyte growth factor/scatter factor. EMBO J. 11(13):4825-4833.
66. Naldini L, Vigna E, Bardelli A, Follenzi A, Galimi F, Comoglio PM. 1995. Biological activation of pro-HGF (hepatocyte growth factor) by urokinase is controlled by a stoichiometric reaction. J Biol Chem. 270(2):603-611.
67. Narindrasorasak S, Kulkarni P, Deschamps P, She YM, Sarkar B. 2007. Characterization and copper binding properties of human COMMD1 (MURR1). Biochemistry. 46(11):3116-3128.
68. Packman S, Palmiter RD, Karin M, O'Toole C. 1987. Metallothionein messenger RNA regulation in the mottled mouse and Menkes kinky hair syndrome. J Clin Invest. 79(5):1338-1342.
69. Poldervaart JH, Favier RP, van den Ingh TSGAM, Penning LC, Rothuizen J. 2009. Canine hepatitis in a referral population: a retrospective overview (2002-2006). J Vet Intern Med. 23(1):72-80.
70. Reed D. 1990. Glutathione: toxicological implications. Annu Rev Pharmacol toxicol. 30:603-631.
71. Roberts EA, Robinson BH, Yang S. 2008. Mitochondrial structure and function in the untreated Jackson toxic milk (tx-j) mouse, a model for Wilson disease. Mol Genet Metab. 93(1):54-65.
72. Roskams T. 2006. Different types of liver progenitor cells and their niches. J Hepatol. 45(1):1-4.
73. Roskams TA, Libbrecht L, Desmet VJ. 2003. Progenitor cells in diseased human liver. Semin Liver Dis. 23(4):385-396.
74. Roskams TA, Theise ND, Balabaud C, Bhagat G, Bhathal PS, Bioulac-Sage P, Brunt EM, Crawford JM, Crosby HA, Desmet V, et al. 2004. Nomenclature of the finer branches of the biliary tree: canals, ductules, and ductular reactions in human livers. Hepatology. 39(6):1739-1745.
75. Santoni-Rugiu E, Jelnes P, Thorgeirsson SS, Bisgaard HC. 2005. Progenitor cells in liver regeneration: molecular responses controlling their activation and expansion. APMIS. 113(11-12):876-902.
76. Sackett SD, Li Z, Hurtt R, Gao Y, Wells RG, Brondell K, Kaestner KH, Greenbaum LE. 2009. Foxl1 is a marker of bipotential hepatic progenitor cells in mice. Hepatology. 49(3):920-929.
77. Salgado S, Garcia J, Vera J, Siller F, Bueno M, Miranda A, Segura A, Grijalva G, Segura J, Orozco H, et al. 2000. Liver cirrhosis is reverted by urokinase-type plasminogen activator gene therapy. Mol Ther. 2(6):545-515.
78. Sawaki M, Enomoto K, Takahashi H, Nakajima Y, Mori M. 1990. Phenotype of preneoplastic and neoplastic liver lesions during spontaneous liver carcinogenesis of LEC rats. Carcinogenesis. 11(10):1857-1861.
79. Scadden DT. 2006. The stem-cell niche as an entity of action. Nature. 441(7097):1075-1079.
80. Scheinberg IH, Jaffe ME, Sternlieb I. 1987. The use of trientine in preventing the effects of interrupting penicillamine therapy in Wilson's disease. N Eng J Med. 317(4):209-213.
81. Schilsky ML, Scheinberg IH, Sternlieb I. 1991. Prognosis of wilsonian chronic active hepatitis. Gastroenterology. 100(3):762-767.
82. Schirmacher P, Geerts A, Jung W, Pietrangelo A, Rogler CE, Diens HP. 1993. The role of Ito cells in the biosynthesis of HGF-SF in the liver. Exs. 65:285-299.
83. Schotanus BA, van den Ingh TSGAM, Penning LC, Rothuizen J, Roskams TA, Spee B. 2009. Cross-species immunohistochemical investigation of the activation of the liver progenitor cell niche in different types of liver disease. Liver Int. 29(8):1241-1252.
84. Shibata C, Mizuguchi T, Kikkawa Y, Nobuoka T, Oshima H, Kawasaki H, Kawamoto M, Katsuramaki T, Mitaka T, Hirata K. 2006. Liver repopulation and longterm function of rat small hepatocyte transplantation as an alternative cell source for hepatocyte transplantation. Liver Transpl. 12(1):78-87.
85. Spee B, Arends B, van den Ingh TSGAM, Brinkhof B, Nederbragt H, IJzer J, Roskams T, Penning LC, Rothuizen J. 2006a. Transforming growth factor B-1 signalling in canine hepatic diseases: new models for human fibrotic liver pathologies. Liver Int. 26(6):716-725.
86. Spee B, Arends B, van den Ingh TSGAM, Penning LC, Rothuizen J. 2006b. Copper metabolism and oxidative stress in chronic inflammatory and cholestatic liver diseases in dogs. J Vet Intern Med. 20(5):1085-1092.
87. Spee B, Arends B, van Wees AM, Bode P, Penning LC, Rothuizen J. 2007. Functional consequences of RNA interference targeting COMMD1 in a canine hepatic cell line in relation to copper toxicosis. Anim Genet. 38(2):168-170.
88. Spee B, Carpino G, Schotanus BA, Katoonizadeh A, Vander Borght S, Gaudio E, Roskams T. 2010. Characterisation of the activated liver progenitor cell niche, potential involvement of Wnt and Notch signaling. Gut. 59(2):247-257.
89. Strand S, Hofmann WJ, Grambihler A, Hug H, Volkmann M, Otto G, Wesch H, Mariani SM, Hack V, Stremmel W, et al. 1998. Hepatic failure and liver cell damage in acute Wilson's disease involve CD95 (APO-1/ Fas)-mediated apoptosis. Nat Med. 4(5):588-593.
90. Tanzi RE, Petrukhin K, Chernov I, Pellequer JL, Wasco W, Ross B, Romano DM, Parano E, Pavone L, Brzustowicz LM, et al. 1993. The Wilson's disease gene is a copper-transporting ATPase with homology to the Menkes's disease gene. Nat Genet. 5(4):344-350.
91. Taub R. 2004. Liver regeneration: from myth to mechanism. Nat Rev Mol Cell Biol. 5(10):836-847.
92. Valko M, Leibfritz D, Moncol J, Cronin MT, Mazur M, Telser J. 2007. Free radicals and antioxidants in normal physiological functions and human disease. Int J Biochem Cell Biol. 39(1):44-84.
93. van den Berghe PV, Stapelbroek JM, Krieger E, de Bie P, van de Graaf SF, de Groot RE, van Beurden E, Spijker E, Houwen RH, Berger R, et al. 2009. Reduced expression of ATP7B affected by Wilson disease-causing mutations is rescued by pharmalogical folding chaperones 4-phenylbutyrate and curcumin. Hepatology. 50(6):1783-1795.
94. van den Ingh TSGAM, Van Winkle TJ, Cullen JM, Charles JA, Desmet VJ. 2006. WSAVA liver standardization group. Standards for clinical and histological diagnosis of canine and feline liver diseases, Chapter 7. Philadelphia (PA): Saunders Elsevier. Chapter 7, Morphological classification of parenchymal disorders of the canine and feline liver; p. 85-101.
95. van de Sluis B, Groot AJ, Vermeulen J, van der Wall E, van Diest PJ, Wijmenga C, Klomp LW, Vooijs M. 2009. COMMD1 promotes pVHL and O2-independent proteolysis of HIF-1alpha via HSP90/70. PLoS One. 4(10):e7332.
96. van de Sluis B, Muller P, Duran K, Chen A, Groot AJ, Klomp LW, Liu PP, Wijmenga C. 2007. Increased activity of hypoxia-inducible factor 1 is associated with early embryonic lethality in commd1 null mice. Mol Cell Biol. 27(11):4142-4156.
97. van de Sluis B, Rothuizen J, Pearson PL, van Oost BA, Wijmenga C. 2002. Identification of a new copper metabolism gene by positional cloning in a purebred dog population. Hum Mol Genet. 11(2):165-173.
98. Vonk WI, Wijmenga C, Berger R, van de Sluis B, Klomp LW. 2010. Cu/Zn Superoxide dismutase maturation and activity are regulated by COMMD1. J Biol Chem. 285(37):28991-289000.
99. Vonk WIM, Wijmenga C, van de Sluis B. 2008. Relevance of understanding mammalian copper homeostasis. Am J Clin Nutr. 88(3):840S-845S.
100. Weber A, Groyer-Picard MT, Franco D, Dagher I. 2009. Hepatocyte transplantation in animal models. Liver Transpl. 15(1):7-14.
101. Weiss KH, Lozoya JC, Tuma S, Gotthardt D, Reichert J, Ehehalt R, Stremmel W, Füllekrug J. 2008a. Copperinduced translocation of the Wilson disease protein ATP7B independent of Murr1/COMMD1 and Rab7. Am J Pathol. 173(6):1783-1794.
102. Weiss TS, Lichtenauer M, Kirchner S, Stock P, Aurich H, Christ B, Brockhoff G, Kunz-Schughart LA, Jauch KW, Schlitt HJ, et al. 2008b. Hepatic progenitor cells from adult human livers for cell transplantation. Gut. 57(8):1129-1138.
103. Wilson SAK. 1912. Progressive lenticular degeneration: a familial nervous disease associated with cirrhosis of the liver. Brain. 34:20-509.
104. Wu J, Forbes JR, Chen HS, Cox DW. 1994. The LEC rat has a deletion in the copper transporting ATPase gene homologous to the Wilson disease gene. Nat Genet. 7(4):541-545.
105. Yang W, Yan HX, Chen L, Liu Q, He YQ, Yu LX, Zhang SH, Huang DD, Tang L, Kong XN, et al. 2008. Wnt/_-catenin signaling contributes to activation of normal and tumorigenic liver progenitor cells. Cancer Res. 68(11):4287-4295.
106. Zimmers TA, McKillop IH, Pierce RH, Yoo JY, Koniaris LG. 2003. Massive liver growth in mice induced by systemic interleukin 6 administration. Hepatology. 38(2):326-334.